Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Benzinga Pro's 5 Stocks To Watch Today

TEVA, TSLA, IMTE

Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user!

Tesla Inc (NASDAQ: TSLA) stock was trading lower by more than 7 percent early Thursday morning. The company's first-quarter earnings report was overshadowed by a bizarre conference call in which CEO Elon Musk dismissed questions from analysts as "boring."

Fitbit Inc (NYSE: FIT) was trading lower by around 5 percent in reaction to the company's first-quarter results. The fitness tracking company's better-than-expected top-and-bottom-line was overshadowed by concerning guidance in which management expects revenue to decline 19 percent due to poor demand for its devices.

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) was trading higher by more than 4 percent. The generic pharmaceutical company reported its first-quarter results and earned 94 cents per share on revenue of $5.1 billion versus expectations of 66 cents per share and $4.8 billion. The company also lifted its EPS guidance from $2.25-$2.50 to $2.40-$2.65.

Integrated Media Technology Ltd (NASDAQ: IMTE) was trading higher by more than 45 percent. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.

Achaogen Inc (NASDAQ: AKAO) lost more than 25 percent in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.

Related Links:

The Market In 5 Minutes: Tesla Earnings, Under Armour's Future, GM, Nvidia, Square And More

27 Stocks Moving In Thursday's Pre-Market Session



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today